Lind Global Fund III LP 13D and 13G filings for Bionano Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:06 pm Purchase | 2025-12-31 | 13G | Bionano Genomics, Inc. BNGO | Lind Global Fund III LP | 1,050,000 9.350% | 535,662 (+104.15%) | Filing |
| 2025-11-14 4:09 pm Sale | 2025-09-30 | 13G | Bionano Genomics, Inc. BNGO | Lind Global Fund III LP | 514,338 9.900% | -491,623 (-48.87%) | Filing |
| 2025-09-24 8:00 pm Purchase | 2025-09-17 | 13G | Bionano Genomics, Inc. BNGO | Lind Global Fund III LP | 1,005,961 9.900% | 1,005,961 (New Position) | Filing |